AN INHALABLE DRY POWDER COMPOSITION FOR PULMONARY DISEASES

The present invention relates to an inhalable composition comprising a therapeutically effective dosage amount of compound (I), 2-{4-[(2S)-1,1-difluoro-2-hydroxypropyl]phenyl}-N-{4-[3-(2-ethylphenyl) pyrazine-2-yl]phenyl}acetamide or a pharmaceutically acceptable salt thereof. Particularly, the pres...

Full description

Saved in:
Bibliographic Details
Main Authors LUGADE, Vijay Ganpat, ARAVAT, Vaijnath Shadakshari, TRIVEDI, Rakshit Kanubhai, NAVHAT, Someshwar Dashrath, ANKAM, Rajesh Verbeerabhadrarao, KULKARNI, Sushrut
Format Patent
LanguageEnglish
Published 04.04.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to an inhalable composition comprising a therapeutically effective dosage amount of compound (I), 2-{4-[(2S)-1,1-difluoro-2-hydroxypropyl]phenyl}-N-{4-[3-(2-ethylphenyl) pyrazine-2-yl]phenyl}acetamide or a pharmaceutically acceptable salt thereof. Particularly, the present invention relates to a inhalable dry powder composition comprising compound (I) or a pharmaceutically acceptable salt thereof. Further, the present invention relates to a method of treating a pulmonary disease using such a composition.
Bibliography:Application Number: US202017754678